Clinical Trials

Clinical Trials

One of the final phases of research, clinical trials allow the exploration of medical research in a human model. From testing new or improved drug treatments to new management or care regimes or to ways to change community behaviours, clinical trials are an essential part of the translation of medical science into clinical care.

Clinical trials are critically important in the evaluation of new treatments to ensure they are effective for patients. They may also provide patients with early access to new treatments that will not be released to the market for another three to four years.

Flinders Medical Oncology Clinical Trials

The Flinders Medical Oncology Clinical Trials department manages a series of cancer clinical trials throughout the year. To obtain adequate numbers of participants and therefore clear results, most clinical trials are spread over many different hospitals, across Australia and/or internationally. Flinders is highly regarded as a site for such ‘multi-site’ trials and the FCIC will enhance this reputation by combining excellent patient care with clinical research focus and expertise.

For more information please call the Research Coordinator on (08) 8204 5511 and ask for pager 20133.

Haematology Clinical Trials

The Department of Haematology at Flinders Medical Centre has a Clinical Trials Unit for research into the diagnosis, monitoring, and treatment of haematological disorders. This includes both blood cancers (leukaemia, lymphoma, myeloma, myelodysplasia and myelproliferative neoplasms) and non‐malignant disorders, such as thrombosis and idiopathic thrombocytopenic purpura (ITP).

Our clinical trials in malignant haematology include Pharma‐sponsored studies and international collaborative group studies along with trials of the Australasian Leukaemia & Lymphoma Group, the major national collaborative group for blood cancers. We are currently running 10 trials of new drug treatments, and 2 quality of life studies that help us to understand the patient’s pathway and point of view during treatment. New trials will be opening in the coming months, and will be featured in a future FCIC newsletter.

Clinical research gives our patients access to innovative treatment, and can also create opportunities for scientific research that use samples collected from patients during treatment.

If you would like further information regarding any of the studies currently available, you can contact the Haematology Clinical Trials Unit – Kayleen Charles on (08) 8204 5453 or

For a list of active studies please download the following:

November 2013